{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:47:30Z","timestamp":1790740050671,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G035517N"],"award-info":[{"award-number":["G035517N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G090914N"],"award-info":[{"award-number":["G090914N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1503418N"],"award-info":[{"award-number":["1503418N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1503815N"],"award-info":[{"award-number":["1503815N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","award":["FAF\u2010F\/2016\/812"],"award-info":[{"award-number":["FAF\u2010F\/2016\/812"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"published-print":{"date-parts":[[2020,7,3]]},"DOI":"10.15252\/embr.201949237","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T09:38:32Z","timestamp":1588066712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["MALT1 targeting suppresses CARD14\u2010induced psoriatic dermatitis in mice"],"prefix":"10.1038","volume":"21","author":[{"given":"Elien","family":"Van Nuffel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2664-3357","authenticated-orcid":false,"given":"Jens","family":"Staal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griet","family":"Baudelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Haegman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Driege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino","family":"Hochepied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna S","family":"Afonina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5704-582X","authenticated-orcid":false,"given":"Rudi","family":"Beyaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"BFEMBR201949237_CR1","doi-asserted-by":"crossref","first-page":"409637","DOI":"10.1155\/2015\/409637","volume":"2015","author":"CJ Connor","year":"2015","unstructured":"Connor CJ, Liu V, Fiedorowicz JG (2015) Exploring the physiological link between psoriasis and mood disorders. Dermatol Res Pract 2015: 409637","journal-title":"Dermatol Res Pract"},{"key":"BFEMBR201949237_CR2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Suarez\u2010Farinas M, Krueger JG (2014) Immunology of psoriasis. Annu Rev Immunol 32: 227\u2013255","journal-title":"Annu Rev Immunol"},{"key":"BFEMBR201949237_CR3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes JE, Chan TC, Krueger JG (2017) Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol 140: 645\u2013653","journal-title":"J Allergy Clin Immunol"},{"key":"BFEMBR201949237_CR4","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.3390\/ijms18122526","volume":"18","author":"F Capon","year":"2017","unstructured":"Capon F (2017) The genetic basis of psoriasis. Int J Mol Sci 18: 2526","journal-title":"Int J Mol Sci"},{"key":"BFEMBR201949237_CR5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajhg.2012.05.010","volume":"91","author":"D Fuchs\u2010Telem","year":"2012","unstructured":"Fuchs\u2010Telem D, Sarig O, van Steensel MA, Isakov O, Israeli S, Nousbeck J, Richard K, Winnepenninckx V, Vernooij M, Shomron N et\u00a0al (2012) Familial pityriasis rubra pilaris is caused by mutations in CARD14. Am J Hum Genet 91: 163\u2013170","journal-title":"Am J Hum Genet"},{"key":"BFEMBR201949237_CR6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","volume":"90","author":"CT Jordan","year":"2012","unstructured":"Jordan CT, Cao L, Roberson ED, Duan S, Helms CA, Nair RP, Duffin KC, Stuart PE, Goldgar D, Hayashi G et\u00a0al (2012) Rare and common variants in CARD14, encoding an epidermal regulator of NF\u2010kappaB, in psoriasis. Am J Hum Genet 90: 796\u2013808","journal-title":"Am J Hum Genet"},{"key":"BFEMBR201949237_CR7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","volume":"90","author":"CT Jordan","year":"2012","unstructured":"Jordan CT, Cao L, Roberson ED, Pierson KC, Yang CF, Joyce CE, Ryan C, Duan S, Helms CA, Liu Y et\u00a0al (2012) PSORS2 is due to mutations in CARD14. Am J Hum Genet 90: 784\u2013795","journal-title":"Am J Hum Genet"},{"key":"BFEMBR201949237_CR8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jid.2016.09.031","volume":"137","author":"E Van Nuffel","year":"2017","unstructured":"Van Nuffel E, Schmitt A, Afonina IS, Schulze\u2010Osthoff K, Beyaert R, Hailfinger S (2017) CARD14\u2010mediated activation of paracaspase MALT1 in keratinocytes: implications for psoriasis. J Invest Dermatol 137: 569\u2013575","journal-title":"J Invest Dermatol"},{"key":"BFEMBR201949237_CR9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.15252\/embr.201642109","volume":"17","author":"IS Afonina","year":"2016","unstructured":"Afonina IS, Van Nuffel E, Baudelet G, Driege Y, Kreike M, Staal J, Beyaert R (2016) The paracaspase MALT1 mediates CARD14\u2010induced signaling in keratinocytes. EMBO Rep 17: 914\u2013927","journal-title":"EMBO Rep"},{"key":"BFEMBR201949237_CR10","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1042\/BCJ20160270","volume":"473","author":"A Howes","year":"2016","unstructured":"Howes A, O'Sullivan PA, Breyer F, Ghose A, Cao L, Krappmann D, Bowcock AM, Ley SC (2016) Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10\u2010MALT1\u2010dependent NF\u2010kappaB activation. Biochem J 473: 1759\u20131768","journal-title":"Biochem J"},{"key":"BFEMBR201949237_CR11","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.jid.2018.03.1525","volume":"138","author":"M Mellett","year":"2018","unstructured":"Mellett M, Meier B, Mohanan D, Schairer R, Cheng P, Satoh TK, Kiefer B, Ospelt C, Nobbe S, Thome M et\u00a0al (2018) CARD14 gain\u2010of\u2010function mutation alone is sufficient to drive IL\u201023\/IL\u201017\u2010mediated psoriasiform skin inflammation in\u00a0vivo. J Invest Dermatol 138: 2010\u20132023","journal-title":"J Invest Dermatol"},{"key":"BFEMBR201949237_CR12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.immuni.2018.05.012","volume":"49","author":"M Wang","year":"2018","unstructured":"Wang M, Zhang S, Zheng G, Huang J, Songyang Z, Zhao X, Lin X (2018) Gain\u2010of\u2010function mutation of Card14 leads to spontaneous psoriasis\u2010like skin inflammation through enhanced keratinocyte response to IL\u201017A. Immunity 49: 66\u201379.e65","journal-title":"Immunity"},{"key":"BFEMBR201949237_CR13","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3389\/fimmu.2018.01136","volume":"9","author":"J Staal","year":"2018","unstructured":"Staal J, Driege Y, Haegman M, Borghi A, Hulpiau P, Lievens L, Gul IS, Sundararaman S, Goncalves A, Dhondt I et\u00a0al (2018) Ancient origin of the CARD\u2010Coiled Coil\/Bcl10\/MALT1\u2010like paracaspase signaling complex indicates unknown critical functions. Front Immunol 9: 1136","journal-title":"Front Immunol"},{"key":"BFEMBR201949237_CR14","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3389\/fimmu.2018.01927","volume":"9","author":"M Juilland","year":"2018","unstructured":"Juilland M, Thome M (2018) Holding all the CARDs: how MALT1 controls CARMA\/CARD\u2010dependent signaling. Front Immunol 9: 1927","journal-title":"Front Immunol"},{"key":"BFEMBR201949237_CR15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-018-0087-2","volume":"19","author":"J Ruland","year":"2019","unstructured":"Ruland J, Hartjes L (2019) CARD\u2010BCL\u201010\u2010MALT1 signalling in protective and pathological immunity. Nat Rev Immunol 19: 118\u2013134","journal-title":"Nat Rev Immunol"},{"key":"BFEMBR201949237_CR16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molmed.2015.12.004","volume":"22","author":"A Demeyer","year":"2016","unstructured":"Demeyer A, Staal J, Beyaert R (2016) Targeting MALT1 proteolytic activity in immunity, inflammation and disease: good or bad? Trends Mol Med 22: 135\u2013150","journal-title":"Trends Mol Med"},{"key":"BFEMBR201949237_CR17","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1172\/JCI99436","volume":"128","author":"L Fontan","year":"2018","unstructured":"Fontan L, Qiao Q, Hatcher JM, Casalena G, Us I, Teater M, Durant M, Du G, Xia M, Bilchuk N et\u00a0al (2018) Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth. J Clin Invest 128: 4397\u20134412","journal-title":"J Clin Invest"},{"key":"BFEMBR201949237_CR18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ccr.2012.11.003","volume":"22","author":"L Fontan","year":"2012","unstructured":"Fontan L, Yang C, Kabaleeswaran V, Volpon L, Osborne MJ, Beltran E, Garcia M, Cerchietti L, Shaknovich R, Yang SN et\u00a0al (2012) MALT1 small molecule inhibitors specifically suppress ABC\u2010DLBCL in\u00a0vitro and in\u00a0vivo. Cancer Cell 22: 812\u2013824","journal-title":"Cancer Cell"},{"key":"BFEMBR201949237_CR19","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.15252\/embj.201488987","volume":"33","author":"M Jaworski","year":"2014","unstructured":"Jaworski M, Marsland BJ, Gehrig J, Held W, Favre S, Luther SA, Perroud M, Golshayan D, Gaide O, Thome M (2014) Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity. EMBO J 33: 2765\u20132781","journal-title":"EMBO J"},{"key":"BFEMBR201949237_CR20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1742-2094-11-124","volume":"11","author":"C Mc Guire","year":"2014","unstructured":"Mc Guire C, Elton L, Wieghofer P, Staal J, Voet S, Demeyer A, Nagel D, Krappmann D, Prinz M, Beyaert R et\u00a0al (2014) Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis. J Neuroinflammation 11: 124","journal-title":"J Neuroinflammation"},{"key":"BFEMBR201949237_CR21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","volume":"22","author":"D Nagel","year":"2012","unstructured":"Nagel D, Spranger S, Vincendeau M, Grau M, Raffegerst S, Kloo B, Hlahla D, Neuenschwander M, Peter von Kries J, Hadian K et\u00a0al (2012) Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC\u2010DLBCL. Cancer Cell 22: 825\u2013837","journal-title":"Cancer Cell"},{"key":"BFEMBR201949237_CR22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00011-018-1207-y","volume":"68","author":"Y Nakamura","year":"2019","unstructured":"Nakamura Y, Igaki K, Komoike Y, Yokoyama K, Tsuchimori N (2019) Malt1 inactivation attenuates experimental colitis through the regulation of Th17 and Th1\/17 cells. Inflamm Res 68: 223\u2013230","journal-title":"Inflamm Res"},{"key":"BFEMBR201949237_CR23","doi-asserted-by":"crossref","first-page":"e111255","DOI":"10.1371\/journal.pone.0111255","volume":"9","author":"JL Harden","year":"2014","unstructured":"Harden JL, Lewis SM, Pierson KC, Suarez\u2010Farinas M, Lentini T, Ortenzio FS, Zaba LC, Goldbach\u2010Mansky R, Bowcock AM, Lowes MA (2014) CARD14 expression in dermal endothelial cells in psoriasis. PLoS One 9: e111255","journal-title":"PLoS One"},{"key":"BFEMBR201949237_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4049\/jimmunol.1700995","volume":"200","author":"M Tanaka","year":"2018","unstructured":"Tanaka M, Kobiyama K, Honda T, Uchio\u2010Yamada K, Natsume\u2010Kitatani Y, Mizuguchi K, Kabashima K, Ishii KJ (2018) Essential role of CARD14 in murine experimental psoriasis. J Immunol 200: 71\u201381","journal-title":"J Immunol"},{"key":"BFEMBR201949237_CR25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s12015-013-9458-z","volume":"9","author":"L Haenebalcke","year":"2013","unstructured":"Haenebalcke L, Goossens S, Naessens M, Kruse N, Farhang Ghahremani M, Bartunkova S, Haigh K, Pieters T, Dierickx P, Drogat B et\u00a0al (2013) Efficient ROSA26\u2010based conditional and\/or inducible transgenesis using RMCE\u2010compatible F1 hybrid mouse embryonic stem cells. Stem Cell Rev 9: 774\u2013785","journal-title":"Stem Cell Rev"},{"key":"BFEMBR201949237_CR26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/gene.20025","volume":"39","author":"A Ramirez","year":"2004","unstructured":"Ramirez A, Page A, Gandarillas A, Zanet J, Pibre S, Vidal M, Tusell L, Genesca A, Whitaker DA, Melton DW et\u00a0al (2004) A keratin K5Cre transgenic line appropriate for tissue\u2010specific or generalized Cre\u2010mediated recombination. Genesis 39: 52\u201357","journal-title":"Genesis"},{"key":"BFEMBR201949237_CR27","doi-asserted-by":"crossref","first-page":"8551","DOI":"10.1073\/pnas.96.15.8551","volume":"96","author":"V Vasioukhin","year":"1999","unstructured":"Vasioukhin V, Degenstein L, Wise B, Fuchs E (1999) The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc Natl Acad Sci USA 96: 8551\u20138556","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201949237_CR28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1073\/pnas.94.1.219","volume":"94","author":"X Wang","year":"1997","unstructured":"Wang X, Zinkel S, Polonsky K, Fuchs E (1997) Transgenic studies with a keratin promoter\u2010driven growth hormone transgene: prospects for gene therapy. Proc Natl Acad Sci USA 94: 219\u2013226","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201949237_CR29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/0019-5154.113945","volume":"58","author":"R Tirumalae","year":"2013","unstructured":"Tirumalae R (2013) Psoriasiform dermatoses: microscopic approach. Indian J Dermatol 58: 290\u2013293","journal-title":"Indian J Dermatol"},{"key":"BFEMBR201949237_CR30","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.3390\/ijms19010179","volume":"19","author":"A Chiricozzi","year":"2018","unstructured":"Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M (2018) Scanning the immunopathogenesis of psoriasis. Int J Mol Sci 19: E179","journal-title":"Int J Mol Sci"},{"key":"BFEMBR201949237_CR31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1346-8138.2011.01483.x","volume":"39","author":"S Morizane","year":"2012","unstructured":"Morizane S, Gallo RL (2012) Antimicrobial peptides in the pathogenesis of psoriasis. J Dermatol 39: 225\u2013230","journal-title":"J Dermatol"},{"key":"BFEMBR201949237_CR32","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2013-02-486217","volume":"121","author":"K De Filippo","year":"2013","unstructured":"De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, Gunzer M, Roers A, Hogg N (2013) Mast cell and macrophage chemokines CXCL1\/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121: 4930\u20134937","journal-title":"Blood"},{"key":"BFEMBR201949237_CR33","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jid.2016.03.002","volume":"136","author":"S Shao","year":"2016","unstructured":"Shao S, Cao T, Jin L, Li B, Fang H, Zhang J, Zhang Y, Hu J, Wang G (2016) Increased Lipocalin\u20102 contributes to the pathogenesis of psoriasis by modulating neutrophil chemotaxis and cytokine secretion. J Invest Dermatol 136: 1418\u20131428","journal-title":"J Invest Dermatol"},{"key":"BFEMBR201949237_CR34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/imcb.1018","volume":"96","author":"M Bardet","year":"2018","unstructured":"Bardet M, Unterreiner A, Malinverni C, Lafossas F, Vedrine C, Boesch D, Kolb Y, Kaiser D, Gluck A, Schneider MA et\u00a0al (2018) The T\u2010cell fingerprint of MALT1 paracaspase revealed by selective inhibition. Immunol Cell Biol 96: 81\u201399","journal-title":"Immunol Cell Biol"},{"key":"BFEMBR201949237_CR35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ni1568","volume":"9","author":"F Rebeaud","year":"2008","unstructured":"Rebeaud F, Hailfinger S, Posevitz\u2010Fejfar A, Tapernoux M, Moser R, Rueda D, Gaide O, Guzzardi M, Iancu EM, Rufer N et\u00a0al (2008) The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat Immunol 9: 272\u2013281","journal-title":"Nat Immunol"},{"key":"BFEMBR201949237_CR36","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/emboj.2011.85","volume":"30","author":"J Staal","year":"2011","unstructured":"Staal J, Driege Y, Bekaert T, Demeyer A, Muyllaert D, Van Damme P, Gevaert K, Beyaert R (2011) T\u2010cell receptor\u2010induced JNK activation requires proteolytic inactivation of CYLD by MALT1. EMBO J 30: 1742\u20131752","journal-title":"EMBO J"},{"key":"BFEMBR201949237_CR37","doi-asserted-by":"crossref","first-page":"e0127083","DOI":"10.1371\/journal.pone.0127083","volume":"10","author":"JW Yu","year":"2015","unstructured":"Yu JW, Hoffman S, Beal AM, Dykon A, Ringenberg MA, Hughes AC, Dare L, Anderson AD, Finger J, Kasparcova V et\u00a0al (2015) MALT1 protease activity is required for innate and adaptive immune responses. PLoS One 10: e0127083","journal-title":"PLoS One"},{"key":"BFEMBR201949237_CR38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.celrep.2016.08.080","volume":"17","author":"LR Klei","year":"2016","unstructured":"Klei LR, Hu D, Panek R, Alfano DN, Bridwell RE, Bailey KM, Oravecz\u2010Wilson KI, Concel VJ, Hess EM, Van Beek M et\u00a0al (2016) MALT1 protease activation triggers acute disruption of endothelial barrier integrity via CYLD cleavage. Cell Rep 17: 221\u2013232","journal-title":"Cell Rep"},{"key":"BFEMBR201949237_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2018.05.009","volume":"50","author":"Y Li","year":"2018","unstructured":"Li Y, Huang S, Huang X, Li X, Falcon A, Soutar A, Bornancin F, Jiang Z, Xin HB, Fu M (2018) Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression. Cell Signal 50: 1\u20138","journal-title":"Cell Signal"},{"key":"BFEMBR201949237_CR40","first-page":"135","volume":"110","author":"JL D'Silva","year":"1956","unstructured":"D'Silva JL, Fisher RA (1956) Chlorpromazine in the management of psoriasis. Ill Med J 110: 135\u2013136","journal-title":"Ill Med J"},{"key":"BFEMBR201949237_CR41","doi-asserted-by":"crossref","first-page":"e102030","DOI":"10.15252\/embj.2019102030","volume":"39","author":"KA Jacobs","year":"2020","unstructured":"Jacobs KA, Andre\u2010Gregoire G, Maghe C, Thys A, Li Y, Harford\u2010Wright E, Trillet K, Douanne T, Alves Nicolau C, Frenel JS et\u00a0al (2020) Paracaspase MALT1 regulates glioma cell survival by controlling endo\u2010lysosome homeostasis. EMBO J 39: e102030","journal-title":"EMBO J"},{"key":"BFEMBR201949237_CR42","first-page":"439","volume":"45","author":"Y Shimamoto","year":"1990","unstructured":"Shimamoto Y, Shimamoto H (1990) Annular pustular psoriasis associated with affective psychosis. Cutis 45: 439\u2013442","journal-title":"Cutis"},{"key":"BFEMBR201949237_CR43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2018.09.002","volume":"143","author":"A Peled","year":"2019","unstructured":"Peled A, Sarig O, Sun G, Samuelov L, Ma CA, Zhang Y, Dimaggio T, Nelson CG, Stone KD, Freeman AF et\u00a0al (2019) Loss\u2010of\u2010function mutations in caspase recruitment domain\u2010containing protein 14 (CARD14) are associated with a severe variant of atopic dermatitis. J Allergy Clin Immunol 143: 173\u2013181.e110","journal-title":"J Allergy Clin Immunol"},{"key":"BFEMBR201949237_CR44","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.4049\/jimmunol.1402254","volume":"194","author":"F Bornancin","year":"2015","unstructured":"Bornancin F, Renner F, Touil R, Sic H, Kolb Y, Touil\u2010Allaoui I, Rush JS, Smith PA, Bigaud M, Junker\u2010Walker U et\u00a0al (2015) Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation. J Immunol 194: 3723\u20133734","journal-title":"J Immunol"},{"key":"BFEMBR201949237_CR45","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.celrep.2014.10.044","volume":"9","author":"A Gewies","year":"2014","unstructured":"Gewies A, Gorka O, Bergmann H, Pechloff K, Petermann F, Jeltsch KM, Rudelius M, Kriegsmann M, Weichert W, Horsch M et\u00a0al (2014) Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation. Cell Rep 9: 1292\u20131305","journal-title":"Cell Rep"},{"key":"BFEMBR201949237_CR46","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3389\/fimmu.2019.01898","volume":"10","author":"A Demeyer","year":"2019","unstructured":"Demeyer A, Skordos I, Driege Y, Kreike M, Hochepied T, Baens M, Staal J, Beyaert R (2019) MALT1 proteolytic activity suppresses autoimmunity in a T cell intrinsic manner. Front Immunol 10: 1898","journal-title":"Front Immunol"},{"key":"BFEMBR201949237_CR47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/gene.1076","volume":"31","author":"J Schaft","year":"2001","unstructured":"Schaft J, Ashery\u2010Padan R, van der Hoeven F, Gruss P, Stewart AF (2001) Efficient FLP recombination in mouse ES cells and oocytes. Genesis 31: 6\u201310","journal-title":"Genesis"},{"key":"BFEMBR201949237_CR48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/75973","volume":"25","author":"CI Rodriguez","year":"2000","unstructured":"Rodriguez CI, Buchholz F, Galloway J, Sequerra R, Kasper J, Ayala R, Stewart AF, Dymecki SM (2000) High\u2010efficiency deleter mice show that FLPe is an alternative to Cre\u2010loxP. Nat Genet 25: 139\u2013140","journal-title":"Nat Genet"},{"key":"BFEMBR201949237_CR49","volume-title":"Genstat for Windows","author":"VSN International","year":"2017","unstructured":"VSN International (2017) Genstat for Windows, 19th edn. Hemel Hempstead, UK: VSN International. Genstat.co.uk","edition":"19th edn"}],"container-title":["The EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.201949237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/embr.201949237","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/embr.201949237\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embr.201949237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.201949237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:40:26Z","timestamp":1779111626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/embr.201949237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7,3]]}},"alternative-id":["BFEMBR201949237"],"URL":"https:\/\/doi.org\/10.15252\/embr.201949237","relation":{},"ISSN":["1469-221X","1469-3178"],"issn-type":[{"value":"1469-221X","type":"print"},{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"6 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.B. is inventor on a patent application (Inhibitors of MALT1 proteolytic activity and uses thereof; WO09065897; applicants: VIB and UGent) and was involved in a research collaboration with Galapagos n.v. that is no longer running. The authors have no additional financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"EMBR201949237"}}